Jia Xu-Dong, Li Ning, Wu Yong-Ning, Yang Xiao-Guang
National Institute for Nutrition and Food Safety, Chinese Center for Disease Control and Prevention, 29 Nanwei Road, Beijing 100050, China.
World J Gastroenterol. 2005 Sep 14;11(34):5381-4. doi: 10.3748/wjg.v11.i34.5381.
To develop a Brown Norway (BN) rat model to determine the potential allergenicity of novel proteins in genetically modified food.
The allergenicity of different proteins were compared, including ovalbumin (OVA), a potent respiratory and food allergen, bovine serum albumin (BSA), a protein that is considered to have a lesser allergenic potential, and potato acid phosphatase (PAP), a non-allergenic protein when administered to BN rats via different routes of exposure (intraperitoneally or by gavage). IgG and IgE antibody responses were determined by ELISA and PCA, respectively. An immunoassay kit was used to determine the plasma histamine level. In addition, possible systemic effect of allergens was investigated by monitoring blood pressure.
OVA provoked very vigorous protein-specific IgG and IgE responses, low grade protein-specific IgG and IgE responses were elicited by BSA, while by neither route did PAP elicit anything. In either routes of exposure, plasma histamine level in BN rats sensitized with OVA was higher than that of BSA or PAP. In addition, an oral challenge with BSA and PAP did not induce any effect on blood pressure, while a temporary drop in systolic blood pressure in few animals of each routes of exposure was found by an oral challenge with OVA.
BN rat model might be a useful and predictive animal model to study the potential allergenicity of novel food proteins.
建立一种棕色挪威(BN)大鼠模型,以确定转基因食品中新型蛋白质的潜在致敏性。
比较不同蛋白质的致敏性,包括卵清蛋白(OVA),一种强效的呼吸道和食物过敏原;牛血清白蛋白(BSA),一种被认为致敏潜力较小的蛋白质;以及马铃薯酸性磷酸酶(PAP),一种对BN大鼠经不同暴露途径(腹腔注射或灌胃)给药时的非致敏性蛋白质。分别通过酶联免疫吸附测定(ELISA)和被动皮肤过敏试验(PCA)测定IgG和IgE抗体反应。使用免疫分析试剂盒测定血浆组胺水平。此外,通过监测血压研究过敏原可能的全身效应。
OVA引发了非常强烈的蛋白质特异性IgG和IgE反应,BSA引发了低水平的蛋白质特异性IgG和IgE反应,而PAP无论通过哪种途径给药均未引发任何反应。在任何一种暴露途径中,用OVA致敏的BN大鼠的血浆组胺水平均高于用BSA或PAP致敏的大鼠。此外,用BSA和PAP进行口服激发对血压没有任何影响,而用OVA进行口服激发时,在每种暴露途径的少数动物中发现收缩压有短暂下降。
BN大鼠模型可能是一种有用的、具有预测性的动物模型,用于研究新型食品蛋白质的潜在致敏性。